✦ LIBER ✦

Platinum-Resistant and Refractory Ovarian Cancer

✍ Scribed by Dr Angeles A. Alvarez, Daniel L. Clarke-Pearson

Book ID: 120840442
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Tongue: English
Weight: 136 KB
Volume: 2
Category: Article
ISSN: 0099-7374
DOI: 10.2165/00024669-200302010-00001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altretamine (Hexamethylmelamine) in Plat

Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II Trial

✍ Maurie Markman; John A. Blessing; David Moore; Harrison Ball; Samuel S. Lentz 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Paclitaxel vs Epidoxorubicin plus Paclit

Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer

✍ Giorgio Bolis; Fabio Parazzini; Giovanna Scarfone; Antonella Villa; Mariangela A 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Docetaxel/irinotecan combination chemoth

Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study

✍ Kimio Ushijima,Toshiharu Kamura… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 185 KB

Perifosine plus docetaxel in patients wi

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

✍ Siqing Fu; Bryan T. Hennessy; Chaan S. Ng; Zhenlin Ju; Kevin R. Coombes; Judith 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 645 KB

Single nedaplatin treatment as salvage c

Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers

✍ Tomoko Goto; Masashi Takano; Rie Ohishi; Norihiro Iwasa; Motohiro Shimizu; Kosei 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Phase 1b-2a study to reverse platinum re

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

✍ Siqing Fu; Wei Hu; Revathy Iyer; John J. Kavanagh; Robert L. Coleman; Charles F. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views